The patent relates to a coated coronary stent and to a method for coating a coronary stent.
Brief outline of the case
The opposition was rejected and the opponent appealed.
The stent according to claim 1 as granted comprises a stent framework and a macrolide immunosuppressive drug-polymer coating, wherein at least 50% of the drug is in crystalline form.